Global Leader In Pharmaceutical Technology
IMD(INCREMENTALLY MODIFIED DRUG) PIPELINE PRODUCTS
| PROJECT CODE | INDICATION | FORMULATION | PRECLINICAL STUDY |
PHASE 1 | PHASE 2 | PHASE 3 | FILED |
| GLA5PR | NEUROPATHIC PAIN |
|
|||||
| GLH1SM | DIABETES |
|
|||||
| GLH10PR | NEUROPATHIC PAIN |
|
|||||
| GLK1SD | DIABETES |
|
|||||
| GLF1MO | ALLERGIC RHINITIS |
|
|||||
| GLF2LE | PARKINSON DISEASE |
|
|||||
| GLF3AP | ATOPIC DERMATITIS |
|
|||||
NME(NEW MOLECULE ENTITY) PIPELINE PRODUCTS
| PROJECT CODE | INDICATION | FORMULATION | PRECLINICAL STUDY |
PHASE 1 | PHASE 2 | PHASE 3 | FILED |
| GLH8NDE | DRY EYE DISEASE |
|
|||||
GENERIC DRUG PIPELINE PRODUCTS
| PROJECT CODE | INDICATION | FORMULATION | PHASE 1 | FILED |
| GL1901 | PARKINSON DISEASE |
|
||
| GLI1AE | HYPERLIPIDEMIA |
|
||
| CWI4TI | POSTMENOPAUSAL OSTEOPOROSIS |
|
||
| PMJ5DE | BIRTH CONTROL |
|
||
| GLK2DM | DIABETES |
|
||
| PMK3UL | BIRTH CONTROL |
|
||
| PMF4TR | MELASMA |
|
||
| PMK4DE | BIRTH CONTROL(NEW DOSE) |
|
||
| PMK5GE | BIRTH CONTROL(NEW DOSE) |
|
||
전화 : 031-739-5220 | 팩스 : 031-739-5224
경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 714호
GLPHARMTECH
Copyright 2014 ⓒ GLPharmTech. All Rights Reserved
Tel : 031-739-5220 | Fax : 031-739-5224 | webmaster@glpt.co.kr
